DBD vs PBI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

DBD

59.7
AI Score
VS
PBI Wins

PBI

66.6
AI Score

Investment Advisor Scores

DBD

60score
Recommendation
HOLD

PBI

67score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DBD PBI Winner
Revenue 1.82B 760.28M DBD
Net Income 20.50M 80.28M PBI
Net Margin 1.1% 10.6% PBI
ROE 2.1% 74.3% PBI
ROA 0.5% 1.4% PBI
Total Assets 3.74B 5.91B PBI
Debt/Equity 0.97 30.27 DBD
Current Ratio 1.27 1.19 DBD

Relative Price Performance (Last 90 Days)

DBD 1M: -19.6% · 3M: -3.4% PBI 1M: -7.7% · 3M: +6.3%

Current Technical Phase

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $69.94

PBI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.4 · Price: $16.48

Fundamentals Snapshot

Metric DBD PBI
Market Cap
Forward P/E 10.0 8.9
Trailing P/E 22.3 13.1
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.5%
Operating Margin 0.1% 0.2%
EPS 3.04 1.23
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, PBI is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.